Plasma visfatin concentration as a surrogate marker for visceral fat accumulation in obese children

Obesity

Volumn 16, Issue 2, 2008, Pages 384-388

  Araki, Shunsuke ^a   Dobashi, Kazushige ^a   Kubo, Kazuyasu ^a   Kawagoe, Rinko ^a   Yamamoto, Yukiyo ^a   Kawada, Yasusada ^a   Asayama, Kohtaro ^a,b   Shirahata, Akira ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b Kanagawa Health Service Association   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BLOOD; BODY COMPOSITION; CASE CONTROL STUDY; CHILD; ETHNOLOGY; FEMALE; HUMAN; INTRAABDOMINAL FAT; JAPAN; MALE; METABOLISM; OBESITY; PHYSIOLOGY; SUBCUTANEOUS FAT;

ADIPOSITY; ADOLESCENT; BIOLOGICAL MARKERS; BODY COMPOSITION; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; JAPAN; LEPTIN; MALE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY; SUBCUTANEOUS FAT;

EID: 39449116058     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2007.54     Document Type: Article

References (33)

1. Maeda K, Okubo K, Shlmomura I et al. Analysis of an expression profile of genes in the human adipose tissue. Gene 1997;190:227-235.
2. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett 2006;580:2917-2921.
3. Fukuhara A, Matsuda M, Nishizawa M et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005;307:426-430.
4. Kralisch S, Klein J, Lossner U et al. Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. J Endocrinol 2005;185:R1-R8.
5. Sethi JK, Vidal-Puig A. Visfatin: the missing link between intra-abdominal obesity and diabetes? Trends Mol Med 2005;11:344-347.
6. Asayama K, Hayashibe H, Dobashi K et al. Increased serum cholesteryl ester transfer protein in obese children. Obes Res 2002;10:439-446.
7. Asayama K, Hayashibe H, Dobashi K et al. Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children. Obes Res 2003;11:1072-1079.
8. Araki S, Dobashi K, Kubo K, Asayama K, Shirahata A. High molecular weight, rather than total, adiponectin levels better reflect metabolic abnormalities associated with childhood obesity. J Clin Endocrinol Metab 2006;91:5113-5116.
9. Yoshida T, Kaneshi T, Shimabukuro T, Sunagawa M, Ohta T. Serum C-reactive protein and its relation to cardiovascular risk factors and adipocytokines in Japanese children. J Clin Endocrinol Metab 2006;91:2133-2137.
10. Haider DG, Holzer G, Schaller G et al. The adipokine visfatin is markedly elevated in obese children. J Pediatr Gastroenterol Nutr 2006;43:548-549.
11. Asayama K, Dobashi K, Hayashibe H et al. Threshold values of visceral fat measures and their anthropometric alternatives for metabolic derangement in Japanese obese boys. Int J Obes Relat Metab Disord 2002;26:208-213.
12. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
13. Golley RK, Magarey AM, Steinbeck KS, Baur LA, Daniels LA. Comparison of metabolic syndrome prevalence using six different definitions in overweight pre-pubertal children enrolled in a weight management study. Int J Obes 2006;30:853-860.
14. Asayama K, Ozeki T, Sugihara S et al. Criteria for medical intervention in obese children: a new definition of "obesity disease" in Japanese children. Pediatr Int 2003;45:642-646.
15. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 2005;366:1059-1062.
16. Arita Y, Kihara S, Ouchi N et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83.
17. Bottner A, Kratzsch J, Muller G et al. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab 2004;89:4053-4061.
18. Zhang Y, Proenca R, Maffel M et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432.
19. Montague CT, Prins JB, Sanders L, Digby JE, O'Rahilly S. Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes 1997;46:342-347.
20. Berndt J, Kloting N, Kralisch S et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 2005;54:2911-2916.
21. Matsuzawa Y. Metabolic syndrome - definition and diagnostic criteria in Japan. J Atheroscbr Thromb 2005;12:301.
22. Pagano C, Pilon C, Olivleri M et al. Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity Is not related to insulin resistance in humans. J Clin Endocrinol Metab 2006;91:3165-3170.
23. Kloting N, Kloting I. Visfatin: gene expression in isolated adipocytes and sequence analysis in obese WOKW rats compared with lean control rats. Biochem Biophys Res Commun 2005;332:1070-1072.
24. Arner R Visfatin - a true or false trail to type 2 diabetes mellitus. J Clin Endocrinol Metab 2006;91:28-30.
25. Haider DG, Schaller G, Kaplotis S et al. The release of the adipocytokine visfatin is regulated by glucose and Insulin. Diabetologia 2006;49:1909-1914.
26. Kralisch S, Klein J, Lossner U et al. Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 2005;289:E586-E590.
27. Curat CA, Wegner V, Sengenes C et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006;49:744-747.
28. Lopez-Bermejo A, Chico-Julia B, Fernandez-Balsells M et al. Serum visfatin increases with progressive beta-cell deterioration. Diabetes 2006;55:2871-2875.
29. Haider DG, Pleiner J, Francesconi M et al. Exercise training lowers plasma visfatin concentrations in patients with type 1 diabetes. J Clin Endocrinol Metab 2006;91:4702-4704.
30. Chen MP, Chung FM, Chang DM et al. Elevated plasma level of vlsfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006;91:295-299.
31. Hufton SE, Moerkerk PT, Brandwljk R et al. A profile of differentially expressed genes in primary colorectal cancer using suppression subtractiva hybridization. FEBS Lett 1999;463:77-82.
32. Otero M, Lago R, Gomez R et al. Changes in plasma levels of fat-derived hormones adiponectin, leptin, reslstin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 2006;65:1198-1201.
33. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005;115:e500-e503.